Abou Warda, A.E.; Sarhan, R.M.; Al-Fishawy, H.S.; Moharram, A.N.; Salem, H.F.
Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges. Pharmaceuticals 2022, 15, 296.
https://doi.org/10.3390/ph15030296
AMA Style
Abou Warda AE, Sarhan RM, Al-Fishawy HS, Moharram AN, Salem HF.
Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges. Pharmaceuticals. 2022; 15(3):296.
https://doi.org/10.3390/ph15030296
Chicago/Turabian Style
Abou Warda, Ahmed E., Rania M. Sarhan, Hussein Saeed Al-Fishawy, Ayman N. Moharram, and Heba F. Salem.
2022. "Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges" Pharmaceuticals 15, no. 3: 296.
https://doi.org/10.3390/ph15030296
APA Style
Abou Warda, A. E., Sarhan, R. M., Al-Fishawy, H. S., Moharram, A. N., & Salem, H. F.
(2022). Continuous Versus Intermittent Linezolid Infusion for Critically Ill Patients with Hospital-Acquired and Ventilator-Associated Pneumonia: Efficacy and Safety Challenges. Pharmaceuticals, 15(3), 296.
https://doi.org/10.3390/ph15030296